2025 HCPCS Code G9132
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
TAGS: prostate disease demonstration therapy limited rising clinical metastases| Short Description | Onc dx prostate mets no cast |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2007 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9507 - Doc reas on statin or contra
- G9508 - Doc pt not on statin
- G9509 - Adit mdd dys rem 12 mnths
- G9510 - Remis12m not phq-9 score <5
- G9511 - Idx evt dte phq>9 doc 12 mo
- G9512 - Indiv pdc > 0.8
- G9513 - Indiv pdc not > 0.8
- G9514 - Req ret or w/in 90d of surg
- G9515 - No reas, no ret or w/in 90d
- G9516 - Impr vis acuit w/in 90d
- G9517 - No impr vis acuit w/in 90d
- G9518 - Doc active inj drug use
- G9519 - Final ref +/- 1.0 w/in 90d
- G9520 - Refract not +/- 1.0 w/in 90d
- G9521 - Er and ip hosp <2 in 12 mos
- G9522 - Er/ip hosp =/>2 in 12 mos
- G9523 - D/c hemo or perit dialysis
- G9524 - Refer to hospice
- G9525 - Doc pt reas no hospice refer
- G9526 - No reason, no refer hospice